Literature DB >> 7979849

Pneumococcal vaccine after 15 years of use. Another view.

D S Fedson1, E D Shapiro, F M LaForce, M A Mufson, D M Musher, J S Spika, R F Breiman, C V Broome.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7979849

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  10 in total

1.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

2.  Pneumococcal Pneumonia.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

3.  Routine adult immunization in Canada: recommendations and performance.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis       Date:  2002-07

4.  Pneumococcal vaccine.

Authors:  K L Hattotuwa; C R Hind
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

5.  Use of pneumococcal vaccine.

Authors:  D S Fedson
Journal:  J Gen Intern Med       Date:  1995-07       Impact factor: 5.128

6.  Identification of D motif epitopes in Staphylococcus aureus fibronectin-binding protein for the production of antibody inhibitors of fibronectin binding.

Authors:  Q Sun; G M Smith; C Zahradka; M J McGavin
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

7.  Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.

Authors:  M A Shelly; H Jacoby; G J Riley; B T Graves; M Pichichero; J J Treanor
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 8.  Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.

Authors:  Julia Ae Walters; Joanne Ngie Qing Tang; Phillippa Poole; Richard Wood-Baker
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

9.  Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials.

Authors:  R A Moore; P J Wiffen; B A Lipsky
Journal:  BMC Fam Pract       Date:  2000-10-04       Impact factor: 2.497

10.  Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.

Authors:  Karen L Ciprero; Rocio D Marchese; Patrick Richard; Martine Baudin; Tina M Sterling; Susan B Manoff; David Radley; Jon E Stek; Benoît Soubeyrand; John D Grabenstein; Sandrine I Samson; Luwy K Musey
Journal:  Hum Vaccin Immunother       Date:  2016-03-22       Impact factor: 3.452
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.